Correlation Between Indaptus Therapeutics and Olema Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Indaptus Therapeutics and Olema Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Indaptus Therapeutics and Olema Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Indaptus Therapeutics and Olema Pharmaceuticals, you can compare the effects of market volatilities on Indaptus Therapeutics and Olema Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Indaptus Therapeutics with a short position of Olema Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Indaptus Therapeutics and Olema Pharmaceuticals.
Diversification Opportunities for Indaptus Therapeutics and Olema Pharmaceuticals
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Indaptus and Olema is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and Olema Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Olema Pharmaceuticals and Indaptus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Indaptus Therapeutics are associated (or correlated) with Olema Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Olema Pharmaceuticals has no effect on the direction of Indaptus Therapeutics i.e., Indaptus Therapeutics and Olema Pharmaceuticals go up and down completely randomly.
Pair Corralation between Indaptus Therapeutics and Olema Pharmaceuticals
Given the investment horizon of 90 days Indaptus Therapeutics is expected to generate 1.64 times less return on investment than Olema Pharmaceuticals. But when comparing it to its historical volatility, Indaptus Therapeutics is 1.3 times less risky than Olema Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Olema Pharmaceuticals is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 557.00 in Olema Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of 76.00 from holding Olema Pharmaceuticals or generate 13.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Indaptus Therapeutics vs. Olema Pharmaceuticals
Performance |
| Timeline |
| Indaptus Therapeutics |
| Olema Pharmaceuticals |
Indaptus Therapeutics and Olema Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Indaptus Therapeutics and Olema Pharmaceuticals
The main advantage of trading using opposite Indaptus Therapeutics and Olema Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Indaptus Therapeutics position performs unexpectedly, Olema Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Olema Pharmaceuticals will offset losses from the drop in Olema Pharmaceuticals' long position.| Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
| Olema Pharmaceuticals vs. Sana Biotechnology | Olema Pharmaceuticals vs. Cullinan Oncology LLC | Olema Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Olema Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |